[YMAB] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
01-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -27.84%
YoY- -85.09%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 12,537 10,797 10,486 9,598 8,965 10,951 5,383 75.61%
PBT -27,526 -41,131 -28,068 -36,893 -28,858 -22,937 33,413 -
Tax 1,509 1,186 373 1,135 0 -216 338 170.88%
NP -29,035 -42,317 -28,441 -36,893 -28,858 -22,937 33,413 -
Tax Rate - - - - - - -1.01% -
Total Cost 41,572 53,114 38,927 46,491 37,823 33,888 -28,030 -
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -231.59 -391.93 -271.23 -384.38 -321.90 -209.45 620.71 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.66 -0.97 -0.65 -0.85 -0.66 -0.53 0.80 -
EPS Diluted -0.66 -0.97 -0.65 -0.85 -0.66 -0.53 0.75 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.